Acquisition of Exclusive Alfasigma Medications - 2026
About This Opportunity
TranslatedThis tender pertains to the acquisition of exclusive medications from Alfasigma for the year 2026. The procurement aims to ensure the availability of specialized pharmaceutical products that are essential for healthcare providers. Interested bidders must demonstrate their capability to supply these exclusive medications in compliance with regulatory standards and quality assurance protocols. Key requirements include the submission of relevant certifications, proof of previous experience in similar contracts, and the ability to meet delivery timelines as specified in the tender documents. The procurement process will be conducted in accordance with applicable public procurement regulations, ensuring transparency and fairness. Bidders are encouraged to review the detailed specifications and terms outlined in the tender documents to prepare their proposals effectively. The location for the delivery of the medications will be specified in the contract, and it is expected that the selected supplier will maintain a robust supply chain to meet the demands of the healthcare sector. This tender represents an important opportunity for pharmaceutical suppliers to engage with a reputable organization and contribute to the healthcare system by providing essential medications.
This is a supplies contract in the health and medical services, information and communication technology and legal services sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 6,042.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Medicamentos Exclusivos Alfasigma - 2026" pertains to the procurement of exclusive pharmaceuticals from Alfasigma, a well-regarded pharmaceutical company. This tender is issued within the context of public health procurement in Portugal, emphasizing the importance of ensuring the availability of vital medications for healthcare providers and patients.
The contracting authority is responsible for overseeing the acquisition process, with the aim of securing high-quality medicinal products that meet established safety and efficacy standards. As this tender focuses on exclusive medications, it is anticipated that suppliers will possess the necessary licenses and certifications to distribute these products within the Portuguese market, adhering to national regulatory requirements.
Typical requirements for participation in this tender may include the demonstration of prior experience in supplying similar pharmaceutical products, compliance with Good Distribution Practice (GDP), and the ability to meet stringent delivery timelines. Additionally, bidders may need to provide evidence of financial stability and the capability to manage logistical aspects associated with the distribution of pharmaceuticals.
Interested parties are encouraged to review the detailed specifications and submission guidelines as outlined on the Portal BASE, which centralizes information on public contracts across mainland Portugal and its autonomous regions. This portal serves as a vital resource for suppliers looking to engage with public health procurement, ensuring transparency and accessibility in the tendering process.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 16, 2026. Last refreshed 7 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Gaia/Espinho, E. P. E.
Unidade Local de Saúde de Gaia/Espinho, E. P. E. has issued 488 procurement notices on BidsFactory, including 0 currently open and 479 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Industry & Manufacturing. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Gaia/Espinho, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €6,042. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Alfasigma Portugal, Lda.. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.